ES2168392T3 - Derivados de flavanonol y compuesto estimulante para la nutricion y crecimiento del cabello que los contiene. - Google Patents

Derivados de flavanonol y compuesto estimulante para la nutricion y crecimiento del cabello que los contiene.

Info

Publication number
ES2168392T3
ES2168392T3 ES95938606T ES95938606T ES2168392T3 ES 2168392 T3 ES2168392 T3 ES 2168392T3 ES 95938606 T ES95938606 T ES 95938606T ES 95938606 T ES95938606 T ES 95938606T ES 2168392 T3 ES2168392 T3 ES 2168392T3
Authority
ES
Spain
Prior art keywords
nutrition
group
growth
sup
hair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95938606T
Other languages
English (en)
Inventor
Susumu Ichinose
Yoshinori Nishizawa
Atsuchi Ohuchi
Hideshi Kidena
Mitsuyuki Hotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP06299223A external-priority patent/JP3131105B2/ja
Priority claimed from JP6299222A external-priority patent/JP3043582B2/ja
Application filed by Kao Corp filed Critical Kao Corp
Application granted granted Critical
Publication of ES2168392T3 publication Critical patent/ES2168392T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE FLAVANONOL REPRESENTADOS POR LA FORMULA (1): (EN DONDE R {SUP,1} REPRESENTA UN GRUPO ALQUILO, Y CADA R {SUP,2} Y R{SUP,3} REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO EL CUAL PUEDE TENER UN SUSTITUYENTE, UN GRUPO ALCOXILO EL CUAL PUEDE TENER UN SUSTITUYENTE, UN GRUPO HIDROXILO, UN GRUPO CIANO O UN ATOMO DE HALOGENO) ASI COMO COMPOSICIONES PARA LA NUTRICION CAPILAR Y EL CRECIMIENTO CAPILAR QUE CONTIENEN LOS DERIVADOS. LOS COMPUESTOS ACELERAN LA DIFERENCIACION Y PROLIFERACION DE LAS CELULAS DE MATRIZ CAPILAR, MOSTRANDO DE ESTA FORMA EFECTOS NOTABLES EN LA NUTRICION CAPILAR Y EL CRECIMIENTO CAPILAR.
ES95938606T 1994-12-02 1995-11-29 Derivados de flavanonol y compuesto estimulante para la nutricion y crecimiento del cabello que los contiene. Expired - Lifetime ES2168392T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP06299223A JP3131105B2 (ja) 1994-12-02 1994-12-02 養毛・育毛料
JP6299222A JP3043582B2 (ja) 1994-12-02 1994-12-02 フラバノノール誘導体

Publications (1)

Publication Number Publication Date
ES2168392T3 true ES2168392T3 (es) 2002-06-16

Family

ID=26561833

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95938606T Expired - Lifetime ES2168392T3 (es) 1994-12-02 1995-11-29 Derivados de flavanonol y compuesto estimulante para la nutricion y crecimiento del cabello que los contiene.

Country Status (5)

Country Link
US (2) US5702691A (es)
EP (1) EP0743311B1 (es)
DE (1) DE69525446T2 (es)
ES (1) ES2168392T3 (es)
WO (1) WO1996016956A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997024134A1 (en) * 1995-12-27 1997-07-10 Taisho Pharmaceutical Co., Ltd. A pharmaceutical composition comprising plant worms and muirapuama
US5916576A (en) * 1997-05-30 1999-06-29 Amway Corporation Method of scavenging free radicals using orange extract
US5874094A (en) * 1997-08-05 1999-02-23 Costello; Jeremiah Cream formulation for topical application
US6099870A (en) * 1997-12-18 2000-08-08 Johnson & Johnson Consumer Companies, Inc. Methods for improving the health of hair and scalp
CA2347907C (en) * 1998-10-23 2009-12-08 Aventis Pharma Deutschland Gmbh Formulations for topical application of substances having an antiandrogenic action
US20020142013A1 (en) * 2001-01-31 2002-10-03 Maes Daniel H. Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function
US20040201694A1 (en) * 2001-02-07 2004-10-14 Vladimir Gartstein Noninvasive methods and apparatus for monitoring at least one hair characteristic
ITMI20012142A1 (it) * 2001-10-17 2003-04-17 Mario Baraldi Composizioni farmaceutiche per uso topico contenenti estratti di erbemedicinali ad attivita' antilogistica e cicatrizzante
US7027982B2 (en) * 2001-12-14 2006-04-11 Microsoft Corporation Quality and rate control strategy for digital audio
GB0216371D0 (en) * 2002-07-13 2002-08-21 Rowett Res Inst The Compounds
KR20040008916A (ko) * 2002-07-19 2004-01-31 주식회사 바이오썸 탈모방지 및 발모촉진 성분을 함유하는 머리비누 및 그제조방법
WO2004010958A2 (en) * 2002-07-31 2004-02-05 Shaklee Corporation A method for maximizing scalp health and inducing enhanced visual and tactile hair quality
BR0315927A (pt) † 2002-10-30 2005-09-20 Asat Ag Applied Science & Tech Unidades para doses únicas diárias de melatonina
DE10333245C5 (de) * 2003-07-21 2015-02-19 Henkel Ag & Co. Kgaa Präbiotisch wirksame Pflanzenextrakte
US20050260152A1 (en) * 2004-05-03 2005-11-24 Jaghab Khalil C Hair growth composition
JP5096742B2 (ja) * 2004-05-21 2012-12-12 正 五井野 頭皮頭髪用組成物
FR2873024A1 (fr) * 2004-07-13 2006-01-20 Oreal Procede de traitement pour prevenir ou diminuer la chute des cheveux
EP1683512B1 (en) * 2004-12-23 2014-03-26 Kao Germany GmbH Hair conditioning composition containing flavone derivatives
US20080059313A1 (en) * 2006-08-30 2008-03-06 Oblong John E Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
US20090098217A1 (en) * 2007-10-10 2009-04-16 Robert Blaszkowski Compositions and methods for promoting thicker hair
BRPI0907970B1 (pt) * 2008-02-29 2020-06-30 The Procter & Gamble Company composição para tratamento dos cabelos ou pelos e método para aumentar o diâmetro dos cabelos ou pelos
GB0906424D0 (en) 2009-04-09 2009-05-20 Antoxis Ltd Use of compounds for differentiation of cells
GB201017315D0 (en) 2010-10-13 2010-11-24 Antoxis Ltd Compound
WO2013022003A1 (ja) * 2011-08-09 2013-02-14 花王株式会社 まゆ毛又はまつ毛用乳化化粧料
US10123966B2 (en) 2013-05-16 2018-11-13 The Procter And Gamble Company Hair thickening compositions and methods of use
US10123991B2 (en) 2015-05-15 2018-11-13 Global Biolife Inc. Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689663A (en) * 1963-08-28 1972-09-05 Merck Ag E Lowering cholesterol blood levels with flavanoids

Also Published As

Publication number Publication date
DE69525446T2 (de) 2002-10-02
DE69525446D1 (de) 2002-03-21
EP0743311B1 (en) 2002-02-13
EP0743311A4 (en) 1997-04-09
US5876703A (en) 1999-03-02
EP0743311A1 (en) 1996-11-20
WO1996016956A1 (fr) 1996-06-06
US5702691A (en) 1997-12-30

Similar Documents

Publication Publication Date Title
ES2168392T3 (es) Derivados de flavanonol y compuesto estimulante para la nutricion y crecimiento del cabello que los contiene.
ECSP941096A (es) Procedimiento para la preparacion de un derivado indol
MX9205988A (es) Nucleosidos biciclicos, oligonucleotidos, procedimiento para su preparacion y productos intermedios.
GT200300296A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
ES2189330T3 (es) Derivados heterociclicos n6 de la adenosina sustituidos.
TR199901034T2 (xx) N�rit b�y�mesinin uyar�lmas� i�in y�ntemler ve bile�imler.
ES2187644T3 (es) Derivados de la acetamida, procedimiento de fabricacion y composicion medicamentosa a base de estos derivados.
DE59005097D1 (de) Verwendung härtbarer Cycloaliphaten-Derivate in Dübelmassen.
ES2104015T3 (es) Derivado del acido metoxiiminoacetico y fungicida agricola/horticola que lo contiene como ingrediente activo.
BRPI0506655A (pt) dehidrofenilahistinas e seus análogos, e sìntese de dehidrofenilahistinas e seus análogos
BRPI0511138A (pt) derivados de pirimidina para o tratamento de desenvolvimento celular anormal
ES2179945T3 (es) Compuestos de tetralina con actividad de resistencia a multiples farmacos.
AR009413A1 (es) Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende
GT199900154A (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
AR005431A1 (es) Ozocolorantes reactivos con componentes de copulacion de la serie de los acidos aminonaftalensulfonicos, naftilaminas utilizadas y productos intermediosformados, en la preparacion de dichos ozocolorantes y utilizacion de los ozocolorantes.
DE69326109D1 (de) Halogen-freie, cyclische, Phosphor enthaltende flammenhemmende Verbindungen
ES2164366T3 (es) Derivados de la distamicina acriloil sustituidos, procedimiento de fabricacion asociado y su utilizacion como agentes antitumorales y antivirales.
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
GT200000049A (es) Compuestos quimicos.
ATE165827T1 (de) Herstellung von n-acetylneuraminsäure-derivaten
ES2038667T5 (es) Un derivado de carbamato de yodopropargilo, un metodo para su produccion y composiciones fungicidas que lo contienen como ingrediente activo.
ES2066546T3 (es) Composicion farmaceutica para inhibir la resorcion osea.
AR009120A1 (es) Una composicion de grasa de urea y mecanismos que contienen tal composicion
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
ES2189956T3 (es) Derivados de quinolina, procedimientos para su preparacion y su uso como medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 743311

Country of ref document: ES